Back

Pharma

3rd Pharma 4.0 Summit

  • 2nd – 3rd October 2024
  • Germany flag Germany Berlin

Welcome to the 3rd Pharma 4.0 Summit in Berlin, Germany on October 2-3, 2024! Join industry experts, leaders, and innovators in exploring the integration of digital technologies into the pharmaceutical industry. Discover the power of AI, big data, IoT, and machine learning that are revolutionising drug development, manufacturing, and patient care. Our esteemed keynote speakers will share insights and experiences on topics like AI applications, precision medicine, cybersecurity, and more. Submit your speaking proposal and network with professionals, researchers, and policymakers. Register early to secure your spot at this premier event shaping the future of Pharma 4.0. Don't miss out!

Read more

About 3rd Pharma 4.0 Summit 

The 3rd Pharma 4.0 Summit is happening on October 2-3, 2024, in Berlin, Germany. Join us and explore the integration of digital technologies and the pharmaceutical industry, transforming drug development, manufacturing, and patient care.

Our summit gathers industry experts, thought leaders, professionals, researchers, and policymakers to discuss the latest trends, advancements, and challenges in Pharma 4.0. Together, we'll explore the power of artificial intelligence, big data analytics, IoT, and machine learning in reshaping healthcare.

Engage with esteemed keynote speakers who will share their knowledge and visionary insights, pushing the boundaries of what's possible. Topics include AI and machine learning applications, transforming drug development, digitalising manufacturing and supply chain, leveraging big data for precision medicine, cybersecurity, IoT in packaging and logistics, blockchain for transparency, and virtual and augmented reality in healthcare.

Connect and collaborate with like-minded professionals, participate in interactive panel discussions, and gain invaluable insights to enhance efficiency, reduce costs, and improve patient outcomes. Join us at the forefront of innovation, shaping the future of #VLPharma40.

Register today for the 3rd Pharma 4.0 Summit in Berlin and secure your place among industry leaders. Don't miss this unique opportunity to be part of a dynamic event where knowledge meets innovation. We look forward to welcoming you in October 2024!

Who Should Attend  

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Principal Scientists, and Engineers specialising in:

  • Medical Devices
  • Robotics & Control
  • CMC (Chemistry, Manufacturing, and Controls)
  • Continuous Processing
  • Cell Culture Technology
  • Commercialisation
  • Digital Strategy & Transformation
  • Data Integrity
  • Diagnostics
  • Quality Assurance/Control
  • Pharmaceutical Manufacturing
  • Product Quality
  • Process Monitoring
  • Packaging
  • Compliance
  • Emerging Technologies
  • Licensing
  • Lifecycle Management
  • Regulatory Affairs & Licensing
  • Risk Management
  • Research & Development
  • Track & Trace
  • Scale-Up & Tech Transfer
  • Sterilization
  • Supply Chain
  • Validation
  • Vaccines
  • Biotechnology
  • Precision Medicine
  • Gene Therapy
  • Bioinformatics
  • Clinical Operations
  • Data Science
  • Pharmacovigilance
  • Market Access
  • Health Economics
  • Digital Marketing
  • Artificial Intelligence Ethics
  • Patient Engagement
  • Sustainability
  • Clinical Research
  • Drug Safety
  • Regulatory Compliance
  • Contract Manufacturing
  • Outsourcing
  • Intellectual Property
  • Pharmacology
  • Formulation Development
  • Clinical Data Management
  • Medical Affairs
  • Health Technology Assessment
  • Supply Chain Optimization
  • Gene Editing
  • Drug Delivery Systems
  • Nutraceuticals
  • Pharmacogenomics

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

Key Practical Learning Points

  • Artificial intelligence and machine learning applications in healthcare and various industries 
  • Transforming drug development and clinical trials using digital technologies 
  • Digitalisation of pharmaceutical manufacturing and supply chain management 
  • Role of AI and machine learning in drug discovery and development 
  • Leveraging big data analytics for precision medicine 
  • Cybersecurity in the pharmaceutical industry: Ensuring data privacy and protection 
  • Applying IoT and sensor technologies for smart pharmaceutical packaging and logistics 
  • Role of blockchain in ensuring transparency and traceability in the pharmaceutical industry 
  • Application of virtual and augmented reality in healthcare and pharmaceuticals 
  • Overcoming regulatory challenges in the adoption of Pharma 4.0 technologies 
  • The future of personalised medicine and patient-centric healthcare

Richard Denk, CH

Senior Consultant Aseptic Processing & Containment

Skan AG

Richard Denk has studied mechanical engineering and did an examination on experts of GMP, qualification and validation, pharmaceutical auditing, phar­maceutical engineering, and quality control at the University of Applied Sciences in Albstadt/Sigmaringen, Germany. Richard works at SKAN AG, headquartered in Allschwil, as the head of sales containment. He founded the expert con­tainment group of the ISPE DACH eight years ago. The containment group published the containment manual in September 2015. Richard has spent nearly 20 years working with highly active/highly hazardous substances and has developed the containment pyramid.

Dr. Alexander Krupp, DE

Innovation Lead, Clinical Development and Operations

Bayer AG

Alexander Krupp is responsible for the transformation of Bayer’s clinical development business towards innovative trial designs and to ensure seamless interactions with the ecosystem of discovery partners. He is passionate about delivering digital strategy in the life sciences industry. Previously, his organisations have delivered plug and play data to be easily usable, e.g. 293m patient records from 30-plus sources. As an enthusiastic executive in global enterprises with a PhD in neuroscience, molecular oncologist and certified paramedic, his professional experience covers the pharmaceutical value chain with a focus on digital health and data strategy.

Dr. Stephen Framil, US

Corporate Global Head of Accessibility

Merck Sharp & Dohme GmbH

As the corporate global head of accessibility at Merck Sharp & Dohme GmbH (MSD), Dr. Stephen Framil has threaded the values of equal access throughout his formative and professional career – from building greenhouses for the Navaho Nation in New Mexico and brick and mortar schools in the Dominican Republic, to creating a Philadelphia inner city tuition-free music conservatory for at-risk neighborhood youth, to performing arts organisations in Pennsylvania and North Carolina that make great music accessible to all through admission free concerts. Steve has brought his multi-faceted diverse experience and sense of mission-calling purpose to mobilise digital accessibility across MSD, unifying thought leadership with business objectives and technical expertise to make the digital landscape accessible to all. Steve has over 25 years of professional experience with executive leadership in business strategy and innovation, policy and governance, procedure and operations, and portfolio management expertise – leading global cross organisational enterprise, consultant, and startup teams in the health and life sciences, finance services, non-profit, information technology, user experience, and marketing.

Dan Bach Kristensen, DK

Principal Scientist

Symphogen

Dan Bach Kristensen holds a PhD in biology and a BSc degree in chemistry. Dan is specialised in protein chemistry and mass spectrometry, which he initially applied in the field of proteome research. For the last 19 years Dan has been working with analytical development in the biopharmaceutical industry, on projects ranging from early discovery to product registration. Clinical indications include bleeding disorders, neutropenia, autoimmune diseases, and oncology. Dan currently works as a principal scientist at Symphogen, a part of Servier, which specialises in the development of antibodies, antibody formats, and antibody mixtures for the treatment of cancer and neuro inflammatory diseases.

Dr. Wolfgang Sommeregger, AT

CEO

QUBICON AG

Wolfgang Sommeregger is co-founder of the company QUBICON AG, which focusses on software for advanced process monitoring and model-based process control. He obtained a degree in biotechnology, as well as a PhD as part of the doctoral program “Biomolecular Technology of Proteins (BioToP)” from the University of Natural Resources and Applied Life Sciences, Vienna (BOKU). During his doctoral studies and his former professional career, he mainly focussed on the improvement of bioprocesses, their monitoring, and control.

Thomas Hauser, DE

Business Development Manager EMEA

G-CON Manufacturing

Thomas Hauser works for G-CON Manufacturing in a business development assignment in the EMEA region to educate the market for offsite prefabricated and prequalified factory and clean-room solutions in a drive to bring forward the pharmaceutical facility of the future concept.

On the other hand, he supports companies in the life science segment mainly for expansion strategies, strategical facility implementation, startup support, and pharmaceutical packaging supply and technologies.

Before 2020, Thomas worked in various leading global positions in business development, strategic implementation, and sales in the pharmaceutical packaging field, namely in injectables and semi-solid and oral-solid packaging. He has more than 25 years of experience dealing with the global life science industry and its market and manufacturing requirements.

Thomas holds an international MBA from the University of Ottawa, Canada, and a BA for European business from the ESB Reutlingen and the ESC Reims.

Lukáš Dvořák, MSc, CZ

Independent Pharmaceutical Consultant

LD Consulting

Lukáš Dvořák is a pharmaceutical consultant with more than 15 years of experience in the pharmaceutical industry over Europe and Asia territories. He mainly focusses on the establishment and maintenance of the pharmaceutical quality systems, both production and quality practice. He has auditor skills and practise and is a professional adjudicator in the Czech Accreditation Institute.

Natasha Hunsjee, CH

Innovation Catalyst

Roche

Fabian Stutz, CH

CEO

Pharmabotix AG

Fabian Stutz is the CEO and founder of Pharmabotix, which is committed to revolutionising pharmaceutical production through innovative automation solutions. Their vision is to assist companies in the pharmaceutical sector in automating and robotising their processes, thereby enhancing the quality of their products, maximising efficiency, and reducing costs. They offer a comprehensive range of services, from feasibility studies to concept development and the realisation of turnkey systems.

Bora Erdemli, CH

Principal

ZS Associates

Bora Erdemli has extensive medical affairs experience, leading ZS’s medical affairs practice in Europe. He has worked with pharmaceutical, biotech and medical technology/device companies globally. His focus has been on helping pharmaceutical companies develop sound medical affairs strategy, devise the right evidence/data generation plan, disseminate the information effectively, and collect/communicate insights back to the organisation.

Bora is a member of Medical Affairs Professional Society (MAPS) digital strategy focus area working group and co-leading the MAPS Switzerland/Nordics chapter. Prior to his current role, Bora worked as a management consultant within the healthcare and pharmaceutical practice of another global consulting firm. Bora holds a PhD in biophysics from the Johns Hopkins University School of Medicine.

Sunil Patel, US

Director of Centre of Excellence

ValGenesis, Inc. 

Sunil has over 17 years of experience working in the engineering and validation fields of cGMP / FDA / EU / ISO regulated industry sectors.  

Sunil has a strong background in Cleaning Validation (CIP, COP, Manual), Process Validation, Process Design, Clean Utilities (WFI, PW, Clean Steam, Clean Air, Clean Gases), HVAC, Project Management, Sterilization and Processing Equipment Validation. Further expertise includes Process Optimization/Improvement, Regulatory Compliance and Risk Management methodologies for the pharmaceutical and biologics industry.  

Prior to joining Valgenesis, Sunil has had variety of Validation roles as consultant and corporate employee with increased responsibilities within Pharmaceutical and Biologics industry including Catalent, Eisai, Pfizer, Teva and Novartis.  

Richard Denk, CH

Senior Consultant Aseptic Processing & Containment

Skan AG

Dr. Alexander Krupp, DE

Innovation Lead, Clinical Development and Operations

Bayer AG

Dr. Stephen Framil, US

Corporate Global Head of Accessibility

Merck Sharp & Dohme GmbH

Dan Bach Kristensen, DK

Principal Scientist

Symphogen

Dr. Wolfgang Sommeregger, AT

CEO

QUBICON AG

Thomas Hauser, DE

Business Development Manager EMEA

G-CON Manufacturing

Lukáš Dvořák, MSc, CZ

Independent Pharmaceutical Consultant

LD Consulting

Natasha Hunsjee, CH

Innovation Catalyst

Roche

Fabian Stutz, CH

CEO

Pharmabotix AG

Bora Erdemli, CH

Principal

ZS Associates

Sunil Patel, US

Director of Centre of Excellence

ValGenesis, Inc. 

BROCHURE  

Request the 3rd Pharma 4.0 Summit brochure and find out the latest topics and ideas that will be shared.    

Request

Please fill in your e-mail address below and we will process your request in a moment.

What our
participants
are saying

I want to extend my gratitude and appreciation for providing such a quality platform for this very important part of our industry!  

1
2
3
4
5

Robert B. Wood IV

Scientist II at FUJIFILM Diosynth Biotechnologies

"We had very interesting discussions with the different participants about our industry and the latest trends. Thanks to Vonlanthen for organizing another great 4.0 oriented event."  

1
2
3
4
5

Paolo Bento

Regional Sales Manager at ILC Dover

"Big thank you to all the speakers at the #VLPharma40I Summit. Fantastic insights from a diverse group of industry experts and great presentations from all involved."  

1
2
3
4
5

Jessica Pearson

Occupational Hygiene Consultant at Armstrong Environmental Limited